Xcout Intel
Rapid Oxygen Co
Rapid Oxygen Co., LLC, led by CEO Richard Imbruce and based in Brooklyn, New York, is commercializing safe portable chemical oxygen delivery systems.
Subscribe to see Rapid Oxygen Co’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Rapid Oxygen Co at a glance
Rapid Oxygen Co is a medical equipment & devices company headquartered in United States. It has raised at least $43.5M across the 6 funding rounds on record. Its most recent funding round, Seed, raised $2M in July 2026. Xcout tracks 1 named person at Rapid Oxygen Co, including Richard Imbruce (Founder).
Rapid Oxygen Co leadership
- Richard ImbruceFounder
Rapid Oxygen Co funding rounds
At least $43.5M raised across the 6 rounds on record. The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $2M | 1 named | |
| Series B | $20M | — | |
| — | $17M | 12 named | |
| SEC Form D filing | $500,000 | — | |
| SEC Form D filing | $1.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Rapid Oxygen Co competitors
A few of Rapid Oxygen Co's closest competitors — see the full list of competitors and alternatives →
Delta Chase, LLC is a research and development company that is designing the SAGE Rebreather, a novel multi-modal platform medical device intended to safely elevate the body's carbon dioxide levels. The device is being developed to treat and alleviate conditions such as sleep apnea, altitude illness, and brain injuries, though its claims have not yet been authorized by the FDA.
VQ Biomedical develops a minimally-invasive intravascular oxygenation catheter designed to deliver supplemental oxygen directly into the bloodstream of hospitalized patients with respiratory failure. The technology provides gas exchange independently of injured lungs to support healing while avoiding the complications of mechanical ventilation or external ECMO pumps. The company serves healthcare providers and critical care patients.
Clyra Medical Technologies, Inc. develops advanced wound management and irrigation products utilizing patent-protected oxidative chemistry. The company serves patients and healthcare providers by offering safe, non-toxic treatments designed to combat microorganisms and aid in wound healing without harming healthy tissue.
410 Medical, Inc. is a medical device company focused on developing innovative technologies for emergency and critical care. Based in Research Triangle Park, North Carolina, the company designs rapid fluid and blood product infusion systems for hospitals and military healthcare.
Profusa, Inc. is a pioneering health technology firm that engineers advanced, bio-integrated sensors. These innovative devices, exemplified by their Lumee™ Oxygen Platform, are designed for uninterrupted observation of internal physiological markers. By leveraging artificial intelligence, Profusa translates this constant stream of data into actionable health insights, primarily to empower individuals and clinicians in the management of persistent health challenges like diabetes and critical limb ischemia.
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
Get Rapid Oxygen Co's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Rapid Oxygen Co in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 6 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access